We are live on ! Find out more
GSK icon

GSK
GSK

639 hedge funds and large institutions have $13.8B invested in GSK in 2013 Q2 according to their latest regulatory filings, with 639 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more call options, than puts

Call options by funds: $124M | Put options by funds: $87.1M

4.49% more ownership

Funds ownership: 0% → 4.49% (+4.5%)

Holders
639
Holders Change
+639
Holders Change %
–
% of All Funds
20.85%
Holding in Top 10
14
Holding in Top 10 Change
+14
Holding in Top 10 Change %
% of All Funds
0.46%
New
639
Increased
–
Reduced
–
Closed
–
Calls
$124M
Puts
$87.1M
Net Calls
+$37.2M
Net Calls Change
+$37.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Dodge & Cox
1
Dodge & Cox
California
$3.09B +$3.14B +49,548,767 New
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$906M +$920M +14,498,470 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$579M +$588M +9,267,732 New
State Street
4
State Street
Massachusetts
$560M +$569M +8,960,491 New
Fisher Asset Management
5
Fisher Asset Management
Washington
$557M +$566M +8,918,620 New
Arrowstreet Capital
6
Arrowstreet Capital
Massachusetts
$511M +$519M +8,173,369 New
Primecap Management
7
Primecap Management
California
$506M +$514M +8,100,684 New
Bank of New York Mellon
8
Bank of New York Mellon
New York
$458M +$466M +7,334,590 New
FMI
9
Fiduciary Management Inc
Wisconsin
$456M +$463M +7,293,136 New
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$375M +$381M +6,005,821 New
Wells Fargo
11
Wells Fargo
California
$366M +$372M +5,856,551 New
Invesco
12
Invesco
Georgia
$323M +$328M +5,174,887 New
Bank of America
13
Bank of America
North Carolina
$170M +$172M +2,713,824 New
ClearBridge Investments
14
ClearBridge Investments
New York
$168M +$171M +2,694,967 New
Ameriprise
15
Ameriprise
Minnesota
$165M +$167M +2,636,410 New
Federated Hermes
16
Federated Hermes
Pennsylvania
$152M +$154M +2,425,710 New
Morgan Stanley
17
Morgan Stanley
New York
$137M +$139M +2,196,544 New
State Farm Mutual Automobile Insurance
18
State Farm Mutual Automobile Insurance
Illinois
$129M +$131M +2,068,240 New
MAA
19
Managed Account Advisors
New Jersey
$126M +$128M +2,010,633 New
CLM
20
ClearBridge LLC (Maryland)
Maryland
$105M +$107M +1,687,565 New
Northern Trust
21
Northern Trust
Illinois
$98.3M +$99.9M +1,573,838 New
BIP
22
Brandes Investment Partners
California
$96.5M +$98.1M +1,545,550 New
Goldman Sachs
23
Goldman Sachs
New York
$87.1M +$88.5M +1,394,885 New
First Manhattan
24
First Manhattan
New York
$83.8M +$83.2M +1,311,166 New
Macquarie Group
25
Macquarie Group
Australia
$83.3M +$84.7M +1,334,261 New
1
2 3 4 5

GSK Hedge Fund Activity: Q2 2013 in Review

639 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q2 2013, worth a combined $13.8B.

Buyers outnumbered sellers: 639 funds opened new GSK positions and 0 closed out — a net gain of 639 holders — while 0 added to existing stakes and 0 trimmed.

  • 639 institutional investors held GSK (GSK) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $13.8B of GSK stock for Q2 2013.
  • 639 funds opened new GSK positions in Q2 2013 and 0 closed out, a net change of +639 holders.

Based on aggregated 13F filings for Q2 2013.